What is ALLO's dilution risk score?

ALLO has a latest available DilutionScore record of 51/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for ALLO, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for ALLO?

DilutionWatch tracks 25 SEC filing types for ALLO including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect ALLO shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For ALLO, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for ALLO tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for ALLO. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

ALLO Dilution Risk Score: 51/100 (HIGH)

Score Breakdown

📋 Offering Ability

97

💰 Cash Runway

25

📊 Float Risk

27

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

⛅

Watch

Minor dilution signals detected

model est. 23%

💰 Capital Raise model 38%

• Active shelf registration ($500M, 67% of market cap)

• Active ATM program with $135M remaining capacity

🔄 Reverse Split model est. 15%

• 52-week low $0.98 has breached $1

🔔 Track ALLO — Get forecast alerts →

Market Data

Market Cap$748.99M

Shares Outstanding345.49M

Float269.64M

Cash$322.61M

Debt$81.05M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 26.1% shares (2026Q1 vs prior)

208 institutional holders · 207.61M shares

#1 Pfizer Inc 22.03M shares

#2 BlackRock, Inc. 19.09M shares

#3 TPG GP A, LLC 18.72M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest60.75M

Days to Cover9.2

% of Float22.5%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2020-12-31

4 INSIDER TRANSACTION 2026-08-25

EFFECT EFFECT 2026-08-20

SC 13G/A BENEFICIAL OWNERSHIP 2026-08-14

S-3 SHELF 2026-08-12

Full SEC filing analysis available with free account →

Recent News

Allogene (ALLO) Q2 2026 Earnings Call Transcript Yahoo Finance · Aug 19

Is Allogene Therapeutics (ALLO) Stock Outpacing Its Medical Peers This Year? Zacks · Aug 17

Allogene Therapeutics, Inc. Q2 2026 Earnings Call Summary Moby · Aug 13

Factual ALLO Dilution Snapshot

Allogene Therapeutics, Inc. (ALLO) has a DilutionScore of 51/100, rated High dilution risk. Score date: August 28, 2026.

Stored shelf registration capacity: $500.0M.
Stored ATM program remaining capacity: $135.0M.
Recent SEC activity tracked for ALLO: 4 on 2026-08-25; EFFECT on 2026-08-20; SC 13G/A on 2026-08-14.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.